Navigation Links
IMMULITE 2500 Growth Hormone (hGH)

ProductsIMMULITE 2500 Growth Hormone (hGH)
Company Siemens Medical Solutions Diagnostics
Item IMMULITE 2500 Growth Hormone (hGH)
Features 
Description IMMULITE 2500 is a high-throughput immunoassay system built around the many positive attributes of the IMMULITE 2000 with the important addition of Logic Driven Incubation (LDI). LDI technology allows assays to be designed for optimal performance with the fastest possible incubation times. This allows for critical assays such as the cardiac biomarkers and HCG to be run in around 15 minutes. Together with the extensive breadth of menu from the IMMULITE 2000 and the ability to increase the labs automation with the Sample Management System (SMS), the IMMULITE 2500 is the ideal system for medium- to high-volume immunoassay laboratories that need to consolidate their testing onto a single platform.
Info Siemens Medical Solutions Diagnostics
Customer Service: 800-255-3232 or 914-631-8000
Web site: http://www.siemens.com/diagnostics-products

Related medicine products :

1. IMMULITE Phenytoin
2. IMMULITE 2000 Troponin I
3. IMMULITE 2500 STAT Troponin I
4. IMMULITE 2000 Cortisol
5. IMMULITE/IMMULITE 1000 Cortisol
6. IMMULITE 2500 Cortisol
7. IMMULITE/IMMULITE 1000 IGF-I
8. IMMULITE 2500 IGF-I
9. IMMULITE 2000 IGF-I
10. IMMULITE/IMMULITE 1000 Growth Hormone (hGH)
11. IMMULITE 2000 Growth Hormone (hGH)
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products:
(Date:6/28/2017)... ... June 28, 2017 , ... ... possible to see through objects, has announced the winners of its "Power to ... its fully programmable, Raspberry Pi-enabled 3D sensor, Walabot . Creators cast submissions ...
(Date:6/28/2017)... NE (PRWEB) , ... June 28, 2017 , ... ... Medical has been recognized for excellence in employee engagement. Omaha-based C&A ... the Achievers 50 Most Engaged Workplaces™ in North America for 2017. ...
(Date:6/28/2017)... ... June 28, 2017 , ... Guide to FDA and ... , No matter on which side of the Atlantic devicemakers do business, this fully ... have to follow. , In addition to the full text of the FDA’s regulations ...
(Date:6/28/2017)... ... June 28, 2017 , ... Eating disorders have the highest ... minutes, at least one person dies as a direct result from an eating disorder ... for qualified treatment providers. The iaedp Foundation meets this challenge by offering what has ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces the participation ... award winning television series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays ... regional supplier of garden pea seed. As demand grew, the small company located in ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... MAITLAND, Fla. , June 8, 2017  Less ... ransomware attack that hit more than 200,000 companies, including hospital ... is being heralded as one of the largest online ... technology in the healthcare market, it is imperative that ... can protect their data from this — and many ...
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: